XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.2

Segment Information (Tables)

9 Months Ended

Oct. 01, 2021

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated

The following table presents sales by product line (in thousands):

			Three Months Ended												Nine Months Ended
			October 1, 2021						October 2, 2020						October 1, 2021						October 2, 2020
Segment sales by product line:
Medical
Cardio & Vascular			$	160,858					$	124,596					$	462,632					$	432,885
Cardiac & Neuromodulation			106,543						72,909						334,700						252,404
Advanced Surgical, Orthopedics & Portable Medical			28,720						30,179						83,380						92,041
Total Medical			296,121						227,684						880,712						777,330
Non-Medical			9,453						8,258						27,352						27,153
Total sales			$	305,574					$	235,942					$	908,064					$	804,483

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

The following table presents income for the Company’s reportable segments (in thousands):

			Three Months Ended												Nine Months Ended
			October 1, 2021						October 2, 2020						October 1, 2021						October 2, 2020
Segment income:
Medical			$	52,347					$	28,777					$	164,311					$	120,903
Non-Medical			2,016						1,214						5,374						4,894
Total segment income			54,363						29,991						169,685						125,797
Unallocated operating income (expenses)(a)			(21,273)						9,767						(62,637)						(32,778)
Operating income			33,090						39,758						107,048						93,019
Unallocated expenses, net			(9,911)						(8,358)						(28,113)						(24,815)
Income before taxes			$	23,179					$	31,400					$	78,935					$	68,204

__________

(a) Unallocated operating income (expenses) for the three and nine months ended October 2, 2020 includes a net gain of $28.2 million related to a patent litigation judgment.

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration